Adrian Marimon
Miami, FLNPI 1770718058
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 175 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Coopersurgical, Inc. at 28.5% of the total. Reporting peaked in 2022 at $687 and has fallen 64.4% since, to $245 in 2025.
Across 175 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopersurgical, Inc.$791
- AbbVie$613
- Hologic Sales And Service, LLC$165
- Mission Pharmacal Company$134
- Medical Device Business Services, Inc.$119
- Evofem Biosciences, Inc.$86
- plus $872 from 20 others
Across 82 payments — averaging $3614.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sumitomo Pharma America, Inc.$128K
- AbbVie$127K
- Myovant Sciences GmbH$40K
- Bayer$2K
What the payments were for
- Food & beverage$2,73999%
- Education$411%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopersurgical, Inc. | 66 | $791 |
| AbbVie(2 entities) | 48 | $613 |
| Hologic Sales And Service, LLC | 7 | $165 |
| Mission Pharmacal Company | 8 | $134 |
| Medical Device Business Services, Inc. | 1 | $119 |
| Evofem Biosciences, Inc. | 4 | $86 |
| BD | 4 | $79 |
| Johnson & Johnson | 2 | $76 |
| Astellas Pharma US Inc | 4 | $74 |
| Exeltis, USA Inc. | 3 | $72 |
| Therapeuticsmd, Inc. | 3 | $65 |
| Avion Pharmaceuticals | 5 | $65 |
| Mylan Pharmaceuticals Inc. | 3 | $56 |
| Mayne Pharma Commercial LLC | 2 | $54 |
| Smith+Nephew | 2 | $50 |
| Biogen | 2 | $48 |
| AMAG Pharmaceuticals, Inc. | 2 | $41 |
| Innovation Technologies Inc | 1 | $27 |
| Pfizer | 1 | $24 |
| Myovant Sciences Inc. | 1 | $24 |
| Shield Therapeutics Inc | 1 | $24 |
| Axonics, Inc. | 1 | $23 |
| Medicem Inc. | 1 | $21 |
| Millicent US Inc | 1 | $19 |
| Gilead | 1 | $17 |
| Duchesnay USA Incorporated | 1 | $15 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.